Anti-Cytokeratin 19 antibody [EP1580Y] - Cytoskeleton Marker,Abcam,AB52625

Anti-Cytokeratin 19 antibody [EP1580Y] - Cytoskeleton Marker (ab52625) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, WB and mIHC. Anti-Cytokeratin 19 antibody [EP1580Y] - Cytoskeleton Marker (ab52625) was first used in a scientific publication in 2008 and has been cited over 231 times in peer reviewed journals. It's performance in IHC in mouse and human samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-Cytokeratin 19 antibody [EP1580Y] - Cytoskeleton Marker (ab52625) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-Cytokeratin 19 antibody [EP1580Y] - Cytoskeleton Marker (ab52625) has 13 independent reviews from customers. Anti-Cytokeratin 19 antibody [EP1580Y] - Cytoskeleton Marker (ab52625) specifically detects Cytokeratin 19 (UniProt ID: P08727; Molecular weight: 45kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EP1580Y - ab195872 . Antibody clone EP1580Y is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, Alexa Fluor ® 647, HRP, Alexa Fluor ® 594, Alexa Fluor ® 555, Alexa Fluor ® 568, APC, PE ( ab192643 , ab192980 , ab193600 , ab203443 , ab203444 , ab203445 , ab224980 , ab224981 ). Cytokeratin 19 (CK19) is a protein marker used to identify epithelial cancers, particularly in the liver, pancreas and gastrointestinal tract, where its presence is often associated with aggressive tumor behaviour and poor prognosis; it is considered a valuable tool for diagnosing and assessing the potential aggressiveness of certain cancers, particularly when positive staining is observed in tumor cells. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .